J Clin Invest. 1973;52(4):965-969. https://doi.org/10.1172/JCI107262. Prostaglandins E 2 and F 2a were formed in response to ADP, L-epinephrine, or collagen by human platelets suspended in plasma containing citrate anticoagulant and stirred at 37°C. The prostaglandins formed by platelets in response to collagen were rapidly released and the amounts formed were proportional to the amount of collagen added. The formation of the prostaglandins was associated with the single wave of aggregation induced by collagen or the second wave of aggregation induced by epinephrine. The above findings are discussed with reference to published studies on the biochemical changes occurring during platelet aggregation. It is suggested that the formation and release of prostaglandins is associated with the secretion of endogenous ADP and 5-hydroxytryptamine.
INTRODUCTION
Aggregation of platelets by exposed subendothelial collagen is generally considered to be a very early stage in hemostasis (1) . Studies in vitro indicate that such aggregation is the consequence of the release of endogenous ADP (2, 3) . Endogenous ADP is also released during aggregation of platelets by epinephrine or by exogenous ADP, and after treatment of platelets with thrombin (4). Since prostaglandins E2 and F2a are known to be formed and released from platelets by thrombin (5, 6) , we investigated whether prostaglandins were produced by collagen, epinephrine, or ADP. METHODS Platelet aggregation. Human blood was collected from the antecubital vein of healthy volunteers (who had not taken aspirin within the previous week) into 0.1 vol of 3.8% This work was presented in part at the 3rd Congress on Thrombosis, 22-26 August 1972, Washington, D. C., and appears in the Abstracts of the Meeting on page 246.
Received for publication 15 November 1972 and in revised formn. 26 January 1973. trisodium citrate. Platelet-rich plasma (PRP)' was prepared by centrifuging the blood at 250 g for 15 min at 20-22°C, and the cell content was determined using a Coulter counter (Coulter Electronics, Inc., Hialeah, Fla.) (average 4.5 X 108 platelets, 9.3 X 100 red cells, and 8.5 X 102 white cells/ml). Aggregation of the platelets was studied photometrically in siliconized test tubes at 37'C with the continuous recording of light transmission (Aggregometer, Chrono-Log Corp., Broomall, Pa.). Routinely, 2.5-ml samples of PRP were used, and 1 ml ethanol was added at the end of the incubation period. ADP sodium salt (Sigma Chemical Co., St. Louis, Mo.) and epinephrine hydrochloride (Sigma) were stored as 1-mM solutions and thrombin (Parke, Davis & Co., Detroit, Mich., Bovine) as a 100 U/ml solution for up to 2 mo at -200C. Collagen suspensions were prepared essentially as described elsewhere (7) and stored for up to 2 wk at 4VC. Extraction and determination of prostaglantdins. The contents of two aggregometer tubes, each of which contained 2.5 ml PRP and 1 ml ethanol, were decanted into a glassstoppered tube containing 5 ml saline and 8 ml ethanol. The pH was adjusted to 3 with 9.2% formic acid, the mixture shaken with 25 ml chloroform, and then centrifuged. The lower chloroform phase containing the prostaglandins was removed and evaporated to dryness int vacto, and the formic acid-free residue was kept overnight under nitrogen (modified from reference 8). Prostaglandins in the residue were partially purified by column chromatography and measured as PGE2 by bioassay on the rat fundus strip or as PGF20 by radioimmunoassay. Recoveries through the above procedure of ['H]PGE2 or ['H]PGF2, (New England Nuclear, Boston, Mass.) were 71.8 (3.6 SD) or 76.5% (3.5 SD), respectively. The methods of bioassay, radioimmunoassay, column chromatography, and thin-layer chromatography (TLC) have been described previously (6) . also rapid in onset, but a second wave of aggregation commenced at about 1 min and continued up to 3 min;
aggregation by collagen was preceded by a lag phase of about 20 s and then continued as one wave. Recordings obtained with plasma from the 11th donor ( Fig. 1 B) were different from those of the other donors: the extent of aggregation in response to ADP was somewhat reduced; no second wave of aggregation was seen in response to epinephrine; the rate and extent of aggregation in response to collagen were markedly reduced. Fig. 2 shows that platelets produced prostaglandins during aggregation with the above agents. Prostaglandins were not detected by biological assay in the prostaglandin fraction of total lipid extracts of saline-treated PRP, and therefore their basal levels in platelets must be very low. However, measurable amounts of prostaglandin were found in 9 of the 11 PRP treated with ADP and in 10 of the 11 PRP treated with epinephrine, collagen, or thrombin, With each of 10 donors, more prostaglandins were formed in response to collagen than to epinephrine or ADP. The donor with atypical aggregation responses did not produce prostaglandins in response to any agent.
To identify the biologically active prostaglandins formed by platelets, the partially purified extracts from 15 nml of collagen-treated PRP were submitted to TLC on silver-impregnated plates (which separate PGE1, PGE2, PGF10, and PGF20). Biological activity was confined to zones corresponding to PGE2 and PGF2. as previously reported for serum (6) . Further evidence that the platelets synthesize PGF2. was obtained by radioimmunoassav. After TLC of a partially purified extract from 10 nml of collagen-treated PRP, material which inhibited the binding of [l H] PGF2. to its antibody was found mainly in the zone corresponding to authentic PGF2o. The values obtained by radioimmunoassay of partially purified extracts of PRP treated with saline (< 1 pmol PGF2./ml), 40 AtM ADP (3.0 pmol/ ml), 40 AM epinephrine (4.4), collagen suspension (6.4), and 1 U/ml thrombin (9.8) suggest that this prostaglandin is produced by platelets in response to a variety of agents.
Prostaglandins E2 and F2. were released from platelet by collagen. Table I shows the results of experiments in which the amounts of prostaglandins in plasma, centrifuged free of aggregated platelets, were compared with the amounts present in PRP before centrifugation. When increasing amounts of collagen suspension were added to PRP, proportionately greater amounts of prostaglandins E2 (from 7.1 pmol/ml with 50 /Al collagen to The time course of prostaglandin formation induced by collagen was compared with corresponding photometric recordings of aggregation ( Fig. 3a ). Prostaglandins were synthesized apparently as aggregation commenced. Synthesis stopped after 5 min incubation with collagen (not shown). In similar experiments with 40 AM epinephrine, the formation of detectable amounts of prostaglandins was associated with a second wave of aggregation (Fig. 3b) . In Fig. 1 ) or 1 U/ml thrombin (which induced clotting). Prostaglandins were determined by biological assay and the broken line indicates the detection limit. Each circle depicts the mean value of duplicate incubations with an average variation from the mean of 17%o. The horizontal lines indicate the means for the normals. The closed circle refers to the donor with abnormal aggregation patterns (Fig. 1) . 0 a-0 0 0s --DISCUSSION We examined prostaglandin formation induced by collagen in some detail because of its possible physiological importance. The prostaglandins detected after treatment of PRP with collagen were the result of synthesis because prostaglandins could not be detected in salinetreated PRP. Their production was proportional to the amount of collagen added to PRP. Moreover, the prostaglandins were found to be entirely extracellular 3 min after the addition of collagen. Therefore, these prostaglandins may act either within the platelet before release or outside the platelet after release. However, the question of positive or negative feedback is complicated. Although exogenous prostaglandin E2 enhances the single wave of ADP-induced aggregation of rat or pig platelets in concentrations of greater than 5 pmol/ml (10) , it inhibits the first wave and enhances the second wave of aggregation of human platelets (9) .
Aggregation by collagen and second wave of aggregation by epinephrine or ADP are generally believed to be caused by endogenous ADP extruded from the platelets into plasma (4) . Therefore, the temporal association between prostaglandin formation and the single wave of collagen-induced aggregation or the second wave of epinephrine-induced aggregation indicates that synthesis of prostaglandins parallels the release of ADP. Although we were unable to detect prostaglandin formation in response to concentrations (1-4 MM) of ADP that caused two waves of aggregation, we could detect their formation with 40 MM ADP. More sensitive assay methods will be required to determine whether prostaglandins are formed during the second wave of ADP-induced aggregation. 
DINS DURING
The platelets from one donor did not produce prosta-EGATION glandins, even in response to thrombin, and showed abnormal patterns of aggregation consistent with diminished release of endogenous ADP. Regardless of the / 8 reason for the abnormalities, their concurrence reinforces the association between prostaglandin formation 7 and the release of ADP. Both abnormalities are virtually identical with those caused by aspirin ingestion (11, 6 12), but we have taken great care in screening our 5 donors and feel reasonably confident that in this case they were not due to any drug. O'Brien (12) has also 4 noted the absence of second wave aggregation with epinephrine in PRP from some donors who have not taken aspirin. 2 It has now been shown that prostaglandins are formed _~during clotting (6), by the action of thrombin on -_--X washed platelets (5) , and, as we show here, during w aggregation by collagen, epinephrine, or ADP. A common feature of all these reactions is that they involve 4 5 e ,8 the selective release of stored 5-hydroxytryptamine, CZ ATP, and ADP from intracellular platelet organelles BINS DURING t d~ (13, 14) . The relevance to this release of the finding iRG O Z X that 5-hydroxytryptamine can act as a coenzyme for REGATION U)Q t ..
prostaglandin biosynthesis (15) remains to be estabt-\ lished.
We have previously suggested that prostaglandins are formed by platelets during hemostasis and throm- 
